13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

Page 12 of 14

Page 12 of 14 – SEC Filing

Exhibit List

Exhibit A. Joint Filing Agreement.

Exhibit B. Item 8 Statement.

Exhibit C. Power of Attorney (1).

(1) Power of Attorney previously filed as Exhibit 24 to a Form
3 with regard to Editas Medicine, Inc. filed with the Securities and Exchange Commission on February 2, 2016 by Deerfield Mgmt
III, L.P., Deerfield Management Company, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt HIF, L.P., Deerfield
Private Design Fund III, L.P. and James E. Flynn.

Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)

Page 12 of 14